North America Pain Management Devices Market

North America Pain Management Devices Market Size (2023 to 2028)

The size of the Pain Management Devices Market in North America was valued at USD 1.48 billion in 2023. It is expected to grow at a CAGR of 8.8% to reach USD 2.26 billion by 2028 during the forecast period. The growing demand for better management techniques from the patient population is a crucial driver of the pain management device market.

The growing number of surgical procedures in North America is fuelling the demand for pain management devices and driving the North American market growth. Pain management devices find extensive use in hospitals for various treatments, including implantation, replacement and surgical interventions. The growing patient population suffering from chronic diseases such as cardiovascular disease and cancer in North America contributes to the growing demand for pain management devices and propels regional market growth. For instance, patients with coronary heart disease require pain relief for nerve and chest pain through the infusion of pumps or neurostimulators. Consequently, pain management devices play a vital role in improving quality of life by reducing stress, blood pressure, and heart rate and aiding in faster healing.

The growing geriatric population in North America is increasing the need for pain management devices and propelling the North American market growth. Geriatric individuals often experience pain, especially due to increasing diabetic cases, presenting a challenge for managing chronic and acute pain. Healthcare providers recommend treatment involving pain management devices to alleviate pain and enhance their quality of life. Moreover, there is a rising demand for pain management devices among women suffering from migraines. Nerve stimulation devices are employed to provide relief from migraine pain. Approximately 20% of the US population suffers from chronic pain.

The growing number of advancements in novel pain management devices further fuels the growth rate of the North American market. Manufacturers are developing devices to address various pain conditions, such as arthritis, spinal cord pain, cancer pain and facial pain. Portable pain management devices designed for home use with proper doctor instructions are being introduced. The growing investments in research and development, strong support from public and private organizations and the approval of these devices to enhance their adoption in healthcare settings further promotes the North American market growth.

The high cost of pain management devices in the North American region majorly hamper the North American market growth. The widespread use of pain medications and ointments, shortage of skilled professionals, lack of awareness and the availability of refurbished devices further impede the growth of the North American market. Potential complications associated with pain management devices include complex injuries, bleeding, and nerve damage, reinforcing the importance of proper usage and training.

This research report on the North American pain management devices market has been segmented and sub-segmented into the following categories:

By Device Type: 

• Neurostimulation Devices
  • Transcutaneous Electrical Nerve Stimulation devices
  • Spinal Cord Stimulation devices
• Ablation Devices
  • Radiofrequency Ablation Devices
  • Cryo Ablation Devices
• Analgesia Infusion Pumps
  • Intrathecal Infusion Pumps
  • External Infusion Pumps

By Application: 

• Neuropathic Pain
• Facial Pain
• Migraine
• Musculoskeletal Pain
• Cancer Pain
• Others

By Mode of Purchase: 

• Counter Purchase
• Prescription Based Purchase

By Country: 

• The United States
• Canada
• Rest of North America

North America held the largest share of the global market in 2022 and is expected to showcase the dominating trend throughout the forecast period owing to factors such as the widespread adoption of advanced medical devices in treatment procedures, substantial investments by the healthcare sector and a growing patient population. Increased availability of pain management devices through both online and offline channels, with operators receiving training through demo classes to enhance their proficiency further fuel the regional market growth.

The U.S. pain management devices market is anticipated to account for the largest share of the North American market during the forecast period. Factors such as a robust presence of manufacturing facilities and key market players majorly drive the U.S. market growth. The rising adoption of pain management devices, a surge in merger and acquisition activities, and favorable reimbursement policies contribute to the U.S. market growth.

Canada is anticipated to account for a notable share of the North American market during the forecast period owing to the growing number of increasing clinical trial centers and the presence of improved infrastructure facilities.

KEY MARKET PLAYERS:

Companies that play a pivotal role in the North American pain management devices market are St. Jude Medical, Inc., Boston Scientific Corporation, Medtronic plc, Baxter International, Stryker Corporation, Pfizer Codman, Shurtleff, B Braun Melsungen AG, and DJO Global LLC.